Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab.

× No keyword cloud information.

4 in total

Review 1. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis.

Authors: Per Soelberg Sorensen
Journal: CNS Drugs Date: 2022-05-19 Impact factor: 6.497

2. Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development.

Authors: Li Xue; Adrienne Clements-Egan; Lakshmi Amaravadi; Mary Birchler; Boris Gorovits; Meina Liang; Heather Myler; Shobha Purushothama; Marta Starcevic Manning; Crystal Sung
Journal: AAPS J Date: 2017-11-06 Impact factor: 4.009

3. Early development of anti-natalizumab antibodies in MS patients.

Authors: B Oliver-Martos; T Órpez-Zafra; P Urbaneja; R Maldonado-Sanchez; L Leyva; O Fernández
Journal: J Neurol Date: 2013-06-14 Impact factor: 4.849

4. Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.

Authors: Jenny Link; Ryan Ramanujam; Michael Auer; Malin Ryner; Signe Hässler; Delphine Bachelet; Cyprien Mbogning; Clemens Warnke; Dorothea Buck; Poul Erik Hyldgaard Jensen; Claudia Sievers; Kathleen Ingenhoven; Nicolas Fissolo; Raija Lindberg; Verena Grummel; Naoimh Donnellan; Manuel Comabella; Xavier Montalban; Bernd Kieseier; Per Soelberg Sørensen; Hans-Peter Hartung; Tobias Derfuss; Andy Lawton; Dan Sikkema; Marc Pallardy; Bernhard Hemmer; Florian Deisenhammer; Philippe Broët; Pierre Dönnes; Julie Davidson; Anna Fogdell-Hahn
Journal: PLoS One Date: 2017-02-07 Impact factor: 3.240

4 in total